Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor
• 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection.
Gespeichert in:
| Autor*in: |
Crocchiolo, Roberto [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
3 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management - Scheen, Marc ELSEVIER, 2022, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:84 ; year:2016 ; pages:24-26 ; extent:3 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jcv.2016.09.008 |
|---|
| Katalog-ID: |
ELV019073941 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV019073941 | ||
| 003 | DE-627 | ||
| 005 | 20230623145718.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcv.2016.09.008 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016003000023.pica |
| 035 | |a (DE-627)ELV019073941 | ||
| 035 | |a (ELSEVIER)S1386-6532(16)30541-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 616.019405 |q OCLC |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.45 |2 bkl | ||
| 100 | 1 | |a Crocchiolo, Roberto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| 264 | 1 | |c 2016 | |
| 300 | |a 3 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. | ||
| 650 | 7 | |a HHV-6 |2 Elsevier | |
| 650 | 7 | |a Haploidentical HSCT |2 Elsevier | |
| 650 | 7 | |a T-cell replete |2 Elsevier | |
| 650 | 7 | |a Viral replication |2 Elsevier | |
| 650 | 7 | |a CMV |2 Elsevier | |
| 700 | 1 | |a Giordano, Laura |4 oth | |
| 700 | 1 | |a Rimondo, Andrea |4 oth | |
| 700 | 1 | |a Bologna, Muriel |4 oth | |
| 700 | 1 | |a Sarina, Barbara |4 oth | |
| 700 | 1 | |a Morabito, Lucio |4 oth | |
| 700 | 1 | |a Bramanti, Stefania |4 oth | |
| 700 | 1 | |a Castagna, Luca |4 oth | |
| 700 | 1 | |a Mineri, Rossana |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Scheen, Marc ELSEVIER |t Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |d 2022 |g Amsterdam [u.a.] |w (DE-627)ELV007727844 |
| 773 | 1 | 8 | |g volume:84 |g year:2016 |g pages:24-26 |g extent:3 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jcv.2016.09.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.45 |j Immunologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 84 |j 2016 |h 24-26 |g 3 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
r c rc |
|---|---|
| matchkey_str |
crocchiolorobertogiordanolaurarimondoand:2016----:uahrevrsrpiainrdcsyoeaoiuratvtoatrloeectmelrnp |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.45 |
| publishDate |
2016 |
| allfields |
10.1016/j.jcv.2016.09.008 doi GBVA2016003000023.pica (DE-627)ELV019073941 (ELSEVIER)S1386-6532(16)30541-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Crocchiolo, Roberto verfasserin aut Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor 2016 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Elsevier Giordano, Laura oth Rimondo, Andrea oth Bologna, Muriel oth Sarina, Barbara oth Morabito, Lucio oth Bramanti, Stefania oth Castagna, Luca oth Mineri, Rossana oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:84 year:2016 pages:24-26 extent:3 https://doi.org/10.1016/j.jcv.2016.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 84 2016 24-26 3 045F 610 |
| spelling |
10.1016/j.jcv.2016.09.008 doi GBVA2016003000023.pica (DE-627)ELV019073941 (ELSEVIER)S1386-6532(16)30541-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Crocchiolo, Roberto verfasserin aut Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor 2016 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Elsevier Giordano, Laura oth Rimondo, Andrea oth Bologna, Muriel oth Sarina, Barbara oth Morabito, Lucio oth Bramanti, Stefania oth Castagna, Luca oth Mineri, Rossana oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:84 year:2016 pages:24-26 extent:3 https://doi.org/10.1016/j.jcv.2016.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 84 2016 24-26 3 045F 610 |
| allfields_unstemmed |
10.1016/j.jcv.2016.09.008 doi GBVA2016003000023.pica (DE-627)ELV019073941 (ELSEVIER)S1386-6532(16)30541-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Crocchiolo, Roberto verfasserin aut Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor 2016 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Elsevier Giordano, Laura oth Rimondo, Andrea oth Bologna, Muriel oth Sarina, Barbara oth Morabito, Lucio oth Bramanti, Stefania oth Castagna, Luca oth Mineri, Rossana oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:84 year:2016 pages:24-26 extent:3 https://doi.org/10.1016/j.jcv.2016.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 84 2016 24-26 3 045F 610 |
| allfieldsGer |
10.1016/j.jcv.2016.09.008 doi GBVA2016003000023.pica (DE-627)ELV019073941 (ELSEVIER)S1386-6532(16)30541-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Crocchiolo, Roberto verfasserin aut Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor 2016 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Elsevier Giordano, Laura oth Rimondo, Andrea oth Bologna, Muriel oth Sarina, Barbara oth Morabito, Lucio oth Bramanti, Stefania oth Castagna, Luca oth Mineri, Rossana oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:84 year:2016 pages:24-26 extent:3 https://doi.org/10.1016/j.jcv.2016.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 84 2016 24-26 3 045F 610 |
| allfieldsSound |
10.1016/j.jcv.2016.09.008 doi GBVA2016003000023.pica (DE-627)ELV019073941 (ELSEVIER)S1386-6532(16)30541-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Crocchiolo, Roberto verfasserin aut Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor 2016 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Elsevier Giordano, Laura oth Rimondo, Andrea oth Bologna, Muriel oth Sarina, Barbara oth Morabito, Lucio oth Bramanti, Stefania oth Castagna, Luca oth Mineri, Rossana oth Enthalten in Elsevier Science Scheen, Marc ELSEVIER Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management 2022 Amsterdam [u.a.] (DE-627)ELV007727844 volume:84 year:2016 pages:24-26 extent:3 https://doi.org/10.1016/j.jcv.2016.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.45 Immunologie VZ AR 84 2016 24-26 3 045F 610 |
| language |
English |
| source |
Enthalten in Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management Amsterdam [u.a.] volume:84 year:2016 pages:24-26 extent:3 |
| sourceStr |
Enthalten in Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management Amsterdam [u.a.] volume:84 year:2016 pages:24-26 extent:3 |
| format_phy_str_mv |
Article |
| bklname |
Immunologie |
| institution |
findex.gbv.de |
| topic_facet |
HHV-6 Haploidentical HSCT T-cell replete Viral replication CMV |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| authorswithroles_txt_mv |
Crocchiolo, Roberto @@aut@@ Giordano, Laura @@oth@@ Rimondo, Andrea @@oth@@ Bologna, Muriel @@oth@@ Sarina, Barbara @@oth@@ Morabito, Lucio @@oth@@ Bramanti, Stefania @@oth@@ Castagna, Luca @@oth@@ Mineri, Rossana @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007727844 |
| dewey-sort |
3610 |
| id |
ELV019073941 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019073941</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623145718.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcv.2016.09.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016003000023.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019073941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1386-6532(16)30541-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.019405</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Crocchiolo, Roberto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HHV-6</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Haploidentical HSCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T-cell replete</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Viral replication</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CMV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giordano, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rimondo, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bologna, Muriel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarina, Barbara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morabito, Lucio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bramanti, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Castagna, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mineri, Rossana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Scheen, Marc ELSEVIER</subfield><subfield code="t">Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007727844</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:84</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:24-26</subfield><subfield code="g">extent:3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcv.2016.09.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">84</subfield><subfield code="j">2016</subfield><subfield code="h">24-26</subfield><subfield code="g">3</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Crocchiolo, Roberto |
| spellingShingle |
Crocchiolo, Roberto ddc 610 ddc 616.019405 bkl 44.45 Elsevier HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| authorStr |
Crocchiolo, Roberto |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007727844 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 616 - Diseases |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV Elsevier |
| topic |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV |
| topic_unstemmed |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV |
| topic_browse |
ddc 610 ddc 616.019405 bkl 44.45 Elsevier HHV-6 Elsevier Haploidentical HSCT Elsevier T-cell replete Elsevier Viral replication Elsevier CMV |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l g lg a r ar m b mb b s bs l m lm s b sb l c lc r m rm |
| hierarchy_parent_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| hierarchy_parent_id |
ELV007727844 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007727844 |
| title |
Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| ctrlnum |
(DE-627)ELV019073941 (ELSEVIER)S1386-6532(16)30541-8 |
| title_full |
Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| author_sort |
Crocchiolo, Roberto |
| journal |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| journalStr |
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
24 |
| author_browse |
Crocchiolo, Roberto |
| container_volume |
84 |
| physical |
3 |
| class |
610 610 DE-600 616.019405 OCLC 610 VZ 44.45 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Crocchiolo, Roberto |
| doi_str_mv |
10.1016/j.jcv.2016.09.008 |
| dewey-full |
610 616.019405 |
| title_sort |
human herpesvirus 6 replication predicts cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| title_auth |
Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| abstract |
• 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. |
| abstractGer |
• 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. |
| abstract_unstemmed |
• 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor |
| url |
https://doi.org/10.1016/j.jcv.2016.09.008 |
| remote_bool |
true |
| author2 |
Giordano, Laura Rimondo, Andrea Bologna, Muriel Sarina, Barbara Morabito, Lucio Bramanti, Stefania Castagna, Luca Mineri, Rossana |
| author2Str |
Giordano, Laura Rimondo, Andrea Bologna, Muriel Sarina, Barbara Morabito, Lucio Bramanti, Stefania Castagna, Luca Mineri, Rossana |
| ppnlink |
ELV007727844 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jcv.2016.09.008 |
| up_date |
2024-07-06T20:29:23.772Z |
| _version_ |
1803862947944988672 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV019073941</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623145718.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jcv.2016.09.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016003000023.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV019073941</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1386-6532(16)30541-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.019405</subfield><subfield code="q">OCLC</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Crocchiolo, Roberto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• 87% of HHV-6 reactivations were followed by a CMV reactivation. • CMV reactivation was 14.5-fold higher in those patients with prior HHV-6 reactivation. • HHV-6 can be considered as a predicting indicator of CMV infection.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HHV-6</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Haploidentical HSCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T-cell replete</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Viral replication</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CMV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giordano, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rimondo, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bologna, Muriel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sarina, Barbara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Morabito, Lucio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bramanti, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Castagna, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mineri, Rossana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Scheen, Marc ELSEVIER</subfield><subfield code="t">Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007727844</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:84</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:24-26</subfield><subfield code="g">extent:3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jcv.2016.09.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">84</subfield><subfield code="j">2016</subfield><subfield code="h">24-26</subfield><subfield code="g">3</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4028225 |